757 related articles for article (PubMed ID: 35025605)
1. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis.
Bjornevik K; Cortese M; Healy BC; Kuhle J; Mina MJ; Leng Y; Elledge SJ; Niebuhr DW; Scher AI; Munger KL; Ascherio A
Science; 2022 Jan; 375(6578):296-301. PubMed ID: 35025605
[TBL] [Abstract][Full Text] [Related]
2. The role of Epstein-Barr virus in the etiology of multiple sclerosis: a current review.
Ruprecht K
Expert Rev Clin Immunol; 2020 Dec; 16(12):1143-1157. PubMed ID: 33152255
[No Abstract] [Full Text] [Related]
3. Epstein-Barr virus, latitude and multiple sclerosis.
Disanto G; Pakpoor J; Morahan JM; Hall C; Meier UC; Giovannoni G; Ramagopalan SV
Mult Scler; 2013 Mar; 19(3):362-5. PubMed ID: 22767435
[TBL] [Abstract][Full Text] [Related]
4. Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis.
Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A
JAMA; 2005 May; 293(20):2496-500. PubMed ID: 15914750
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study.
Ascherio A; Munger KL; Lennette ET; Spiegelman D; Hernán MA; Olek MJ; Hankinson SE; Hunter DJ
JAMA; 2001 Dec; 286(24):3083-8. PubMed ID: 11754673
[TBL] [Abstract][Full Text] [Related]
6. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: Epstein-Barr virus and multiple sclerosis: epidemiological evidence.
Ascherio A; Munger KL
Clin Exp Immunol; 2010 Apr; 160(1):120-4. PubMed ID: 20415861
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus and multiple sclerosis.
Ascherio A; Munch M
Epidemiology; 2000 Mar; 11(2):220-4. PubMed ID: 11021623
[TBL] [Abstract][Full Text] [Related]
8. Multiple sclerosis and Epstein-Barr virus.
Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A
JAMA; 2003 Mar; 289(12):1533-6. PubMed ID: 12672770
[TBL] [Abstract][Full Text] [Related]
9. Primary infection with the Epstein-Barr virus and risk of multiple sclerosis.
Levin LI; Munger KL; O'Reilly EJ; Falk KI; Ascherio A
Ann Neurol; 2010 Jun; 67(6):824-30. PubMed ID: 20517945
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr Virus and Multiple Sclerosis: New Light on an Old Idea BjornevikKCorteseMHealyBCKuhleJMinaMJLengY, and others. 2022. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science375(6578):296-301. LanzTVBrewerRCHoPPMoonJSJudeKMFernandezD, and others. Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM. Nature2022;603:321-7.
Neuroscientist; 2022 Apr; 28(2):97. PubMed ID: 35441540
[No Abstract] [Full Text] [Related]
11. Study of soldiers implicates common virus as MS trigger.
Kaiser J
Science; 2022 Jan; 375(6577):133. PubMed ID: 35025651
[No Abstract] [Full Text] [Related]
12. Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel.
Munger KL; Levin LI; O'Reilly EJ; Falk KI; Ascherio A
Mult Scler; 2011 Oct; 17(10):1185-93. PubMed ID: 21685232
[TBL] [Abstract][Full Text] [Related]
13. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
Farrell RA; Antony D; Wall GR; Clark DA; Fisniku L; Swanton J; Khaleeli Z; Schmierer K; Miller DH; Giovannoni G
Neurology; 2009 Jul; 73(1):32-8. PubMed ID: 19458321
[TBL] [Abstract][Full Text] [Related]
14. High seroprevalence of Epstein-Barr virus in children with multiple sclerosis.
Pohl D; Krone B; Rostasy K; Kahler E; Brunner E; Lehnert M; Wagner HJ; Gärtner J; Hanefeld F
Neurology; 2006 Dec; 67(11):2063-5. PubMed ID: 17159123
[TBL] [Abstract][Full Text] [Related]
15. Plasma viral load of Epstein-Barr virus and risk of multiple sclerosis.
Wagner HJ; Munger KL; Ascherio A
Eur J Neurol; 2004 Dec; 11(12):833-4. PubMed ID: 15667414
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus cause of multiple sclerosis.
Tselis A
Curr Opin Rheumatol; 2012 Jul; 24(4):424-8. PubMed ID: 22617821
[TBL] [Abstract][Full Text] [Related]
17. A role of late Epstein-Barr virus infection in multiple sclerosis.
Haahr S; Plesner AM; Vestergaard BF; Höllsberg P
Acta Neurol Scand; 2004 Apr; 109(4):270-5. PubMed ID: 15016009
[TBL] [Abstract][Full Text] [Related]
18. Seroepidemiology of Epstein-Barr virus and cytomegalovirus among Israeli male young adults.
Levine H; Balicer RD; Rozhavski V; Halperin T; Shreberk M; Davidovitch N; Huerta-Hartal M; Ankol OE
Ann Epidemiol; 2012 Nov; 22(11):783-8. PubMed ID: 22831994
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus as a leading cause of multiple sclerosis: mechanisms and implications.
Bjornevik K; Münz C; Cohen JI; Ascherio A
Nat Rev Neurol; 2023 Mar; 19(3):160-171. PubMed ID: 36759741
[TBL] [Abstract][Full Text] [Related]
20. Altered prevalence and reactivity of anti-Epstein-Barr virus antibodies in patients with multiple sclerosis.
Wagner HJ; Hennig H; Jabs WJ; Siekhaus A; Wessel K; Wandinger KP
Viral Immunol; 2000; 13(4):497-502. PubMed ID: 11192296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
